Annual Cash & Cash Equivalents
$548.70 K
-$9.51 M-94.54%
31 December 2023
Summary:
CNS Pharmaceuticals annual cash & cash equivalents is currently $548.70 thousand, with the most recent change of -$9.51 million (-94.54%) on 31 December 2023. During the last 3 years, it has fallen by -$13.49 million (-96.09%). CNSP annual cash & cash equivalents is now -96.09% below its all-time high of $14.04 million, reached on 31 December 2020.CNSP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$6.97 M
+$5.48 M+367.49%
30 September 2024
Summary:
CNS Pharmaceuticals quarterly cash and cash equivalents is currently $6.97 million, with the most recent change of +$5.48 million (+367.49%) on 30 September 2024. Over the past year, it has increased by +$6.06 million (+666.70%). CNSP quarterly cash and cash equivalents is now -50.33% below its all-time high of $14.04 million, reached on 31 December 2020.CNSP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNSP Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -94.5% | +666.7% |
| 3 y3 years | -96.1% | -16.3% |
| 5 y5 years | +94.1% | +1006.7% |
CNSP Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -96.1% | at low | -44.0% | +1170.8% |
| 5 y | 5 years | -96.1% | +94.1% | -50.3% | +1170.8% |
| alltime | all time | -96.1% | +396.6% | -50.3% | +2366.6% |
CNS Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.97 M(+367.5%) |
| June 2024 | - | $1.49 M(+83.0%) |
| Mar 2024 | - | $815.20 K(+48.6%) |
| Dec 2023 | $548.70 K(-94.5%) | $548.70 K(-39.7%) |
| Sept 2023 | - | $909.50 K(-78.7%) |
| June 2023 | - | $4.28 M(-16.3%) |
| Mar 2023 | - | $5.11 M(-49.2%) |
| Dec 2022 | $10.06 M(+100.9%) | $10.06 M(+43.1%) |
| Sept 2022 | - | $7.03 M(-21.6%) |
| June 2022 | - | $8.96 M(-28.0%) |
| Mar 2022 | - | $12.44 M(+148.6%) |
| Dec 2021 | $5.00 M | $5.00 M(-39.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $8.33 M(+20.9%) |
| June 2021 | - | $6.89 M(-37.8%) |
| Mar 2021 | - | $11.08 M(-21.1%) |
| Dec 2020 | $14.04 M(+93.9%) | $14.04 M(+974.1%) |
| Sept 2020 | - | $1.31 M(-50.2%) |
| June 2020 | - | $2.63 M(-51.2%) |
| Mar 2020 | - | $5.38 M(-25.7%) |
| Dec 2019 | $7.24 M(+2461.5%) | $7.24 M(+1049.2%) |
| Sept 2019 | - | $630.10 K(-30.9%) |
| June 2019 | - | $911.90 K(+222.6%) |
| Dec 2018 | $282.70 K(+155.8%) | $282.70 K |
| Dec 2017 | $110.50 K | - |
FAQ
- What is CNS Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is CNS Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is CNS Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of CNSP is $548.70 K
What is the all time high annual cash & cash equivalents for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual cash & cash equivalents is $14.04 M
What is CNS Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, CNSP annual cash & cash equivalents has changed by -$9.51 M (-94.54%)
What is CNS Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CNSP is $6.97 M
What is the all time high quarterly cash and cash equivalents for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly cash and cash equivalents is $14.04 M
What is CNS Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, CNSP quarterly cash and cash equivalents has changed by +$6.06 M (+666.70%)